rs148619105
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS1
This summary comes from the ClinGen Evidence Repository: The c.4004G>A (p.Gly1335Glu) variant in TECTA gene has been detected in heterozygosity in 1 individual with sloping moderately-severe sensorineural hearing loss but no variant on the other allele was identified (Partners LMM internal data). The filtering allele frequency of the variant in the TECTA gene is 0.358% for African chromosomes in gnomAD (89/24844 with 95% CI), which is a high enough frequency to be classified as likely benign based on the thresholds defined by the ClinGen Hearing Loss Expert Panel (HL EP) for autosomal recessive hearing loss variants (BS1). In summary, the HL EP classified this variant as likely benign. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BS1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA6327326/MONDO:0019497/005
Frequency
Consequence
NM_005422.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00100 AC: 153AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000243 AC: 61AN: 250702Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135748
GnomAD4 exome AF: 0.0000889 AC: 130AN: 1461740Hom.: 0 Cov.: 31 AF XY: 0.0000660 AC XY: 48AN XY: 727168
GnomAD4 genome AF: 0.00100 AC: 153AN: 152360Hom.: 0 Cov.: 33 AF XY: 0.000980 AC XY: 73AN XY: 74510
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 03, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 08, 2022 | Located in the zona adhesion region (Hildebrand et al., 2011); Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 22, 2016 | p.Gly1335Glu in exon 11 of TECTA: This variant is not expected to have clinical significance because it has been identified in 0.3% (38/10052) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs148619105). - |
Nonsyndromic genetic hearing loss Benign:1
Likely benign, reviewed by expert panel | curation | ClinGen Hearing Loss Variant Curation Expert Panel | Apr 08, 2021 | The c.4004G>A (p.Gly1335Glu) variant in TECTA gene has been detected in heterozygosity in 1 individual with sloping moderately-severe sensorineural hearing loss but no variant on the other allele was identified (Partners LMM internal data). The filtering allele frequency of the variant in the TECTA gene is 0.358% for African chromosomes in gnomAD (89/24844 with 95% CI), which is a high enough frequency to be classified as likely benign based on the thresholds defined by the ClinGen Hearing Loss Expert Panel (HL EP) for autosomal recessive hearing loss variants (BS1). In summary, the HL EP classified this variant as likely benign. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BS1. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at